Abbott Diagnostics: Medtech Market Ripple Effects and Sector Shifts

Abbott Laboratories missed revenue expectations due to weakness in diagnostics, pressuring medtech sentiment. Investors are reassessing testing demand and pricing, favoring companies in reference labs, life-science tools, and specialty diagnostics, while cautioning against broad…

Listen